FDA clearance of HG202 marks a significant milestone for CRISPR/Cas13 RNA-editing in clinical applications for nAMD. The ...
Vevye will be included in key formularies of major plan sponsors, covering over 25 million Medicare Part D beneficiaries ...
Pediatric cataract surgeries are more costly than adult procedures, with significant nonsurgical expenses like anesthesia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback